SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kilitch Drugs India informs about compliance certificate

15 Jan 2026 Evaluate

Kilitch Drugs India has informed that it enclosed the Certificate received from MUFG Intime India, the Registrar and Share Transfer Agent of the Company for the quarter ended 31st December, 2025.

The above information is a part of company’s filings submitted to BSE.

Kilitch Drugs(India) Share Price

154.25 2.25 (1.48%)
06-May-2026 09:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.55
Dr. Reddys Lab 1281.00
Cipla 1337.40
Zydus Lifesciences 918.00
Lupin 2370.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×